NEULANDLAB quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Neuland Laboratories Ltd reported sales of ₹450 Cr, operating profit of ₹98 Cr (OPM 22%) and net profit of ₹52 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
NEULANDLAB quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
398
328
293
514
440
776
642
450
YoY Sales growth
1
-15
-33
65
10
136
119
-13
Expenses
311
277
258
359
363
469
419
352
Operating Profit
87
51
34
156
77
307
223
98
OPM
22%
16%
12%
30%
18%
40%
35%
22%
Other Income
60
7
8
2
8
12
8
8
Interest
2
2
5
5
7
7
7
7
Depreciation
16
17
20
23
24
25
27
29
Profit before tax
128
39
18
129
54
287
198
69
Tax
20%
29%
21%
25%
26%
26%
25%
25%
Net Profit
102
28
14
97
41
213
148
52
EPS in Rs
79.18
21.68
10.83
75.49
31.62
165.76
115.1
40.24
NEULANDLAB profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
951
1,191
1,559
1,477
2,023
2,307
Sales growth
2
25
31
-5
37
50
Expenses
807
918
1,096
1,146
1,443
1,602
Operating Profit
144
273
463
331
580
705
OPM
15%
23%
30%
22%
29%
31%
Other Income
0
9
12
90
25
36
Interest
14
13
14
8
24
28
Depreciation
49
53
60
66
92
104
Profit before tax
82
216
401
346
489
609
Tax
22%
24%
25%
25%
26%
-
Net Profit
64
164
300
260
364
453
EPS in Rs
49.74
127.45
233.89
202.74
283.71
352.72
Dividend Payout
10%
8%
6%
6%
12%
-
NEULANDLAB balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
13
13
13
13
13
Reserves
1,270
1,512
1,607
1,862
2,017
Borrowings
95
157
265
301
342
Other Liabilities
454
498
649
754
658
Total Liabilities
1,833
2,180
2,534
2,930
3,030
Fixed Assets
824
955
1,076
1,177
1,278
CWIP
46
48
140
211
284
Investments
1
109
114
2
2
Other Assets
962
1,068
1,204
1,541
1,465
Total Assets
1,833
2,180
2,534
2,930
3,030
NEULANDLAB cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
60
237
261
317
347
Cash from Investing Activity
-95
-61
-150
-298
-423
Cash from Financing Activity
38
-136
-69
25
21
Net Cash Flow
3
40
42
44
-55
Free Cash Flow
-37
173
119
112
-50
CFO/OP
56%
103%
81%
119%
78%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit